Advertisement
Review Article| Volume 58, ISSUE 2, P511-530, April 2011

Download started.

Ok

Food Allergy Therapy: Is a Cure Within Reach?

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Pediatric Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sicherer S.H.
        • Sampson H.A.
        Food allergy: recent advances in pathophysiology and treatment.
        Annu Rev Med. 2009; 60: 261-277
        • Branum A.M.
        • Lukacs S.L.
        Food allergy among children in the United States.
        Pediatrics. 2009; 124: 1549-1555
        • Skripak J.M.
        • Sampson H.A.
        Towards a cure for food allergy.
        Curr Opin Immunol. 2008; 20: 690-696
        • Scurlock A.M.
        • Burks A.W.
        • Jones S.M.
        Oral immunotherapy for food allergy.
        Curr Allergy Asthma Rep. 2009; 9: 186-193
        • Shreffler W.G.
        • Beyer K.
        • Chu T.H.
        • et al.
        Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes.
        J Allergy Clin Immunol. 2004; 113: 776-782
        • Flinterman A.E.
        • Knol E.F.
        • Lencer D.A.
        • et al.
        Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy.
        J Allergy Clin Immunol. 2008; 121: 737-743
        • Wang J.
        • Lin J.
        • Bardina L.
        • et al.
        Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy.
        J Allergy Clin Immunol. 2010; 125: 695-702
        • Cooke S.K.
        • Sampson H.A.
        Allergenic properties of ovomucoid in man.
        J Immunol. 1997; 159: 2026-2032
        • Chatchatee P.
        • Jarvinen K.M.
        • Bardina L.
        • et al.
        Identification of IgE- and IgG-binding epitopes on alpha(s1)-casein: differences in patients with persistent and transient cow’s milk allergy.
        J Allergy Clin Immunol. 2001; 107: 379-383
        • Savage J.H.
        • Matsui E.C.
        • Skripak J.M.
        • et al.
        The natural history of egg allergy.
        J Allergy Clin Immunol. 2007; 120: 1413-1417
        • Skripak J.M.
        • Matsui E.C.
        • Mudd K.
        • et al.
        The natural history of IgE-mediated cow’s milk allergy.
        J Allergy Clin Immunol. 2007; 120: 1172-1177
        • MacGlashan D.W.J.
        • Bochner B.S.
        • Adelman D.C.
        • et al.
        Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.
        J Immunol. 1997; 158: 1438-1445
        • Leung D.Y.
        • Sampson H.A.
        • Yunginger J.W.
        • et al.
        Effect of anti-IgE therapy in patients with peanut allergy.
        N Engl J Med. 2003; 348: 986-993
        • Kuehr J.
        • Brauburger J.
        • Zielen S.
        • et al.
        Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.
        J Allergy Clin Immunol. 2002; 109: 274-280
        • Li X.M.
        • Zhang T.F.
        • Huang C.K.
        • et al.
        Food allergy herbal formula -1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model.
        J Allergy Clin Immunol. 2001; 108: 639-646
        • Srivastava K.D.
        • Kattan J.D.
        • Zou Z.M.
        • et al.
        The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy.
        J Allergy Clin Immunol. 2005; 115: 171-178
        • Wang J.
        • Patil S.P.
        • Yang N.
        • et al.
        Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study.
        Ann Allergy Asthma Immunol. 2010; 105: 75-84
        • Qu C.
        • Srivastava K.
        • Ko J.
        • et al.
        Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma.
        Clin Exp Allergy. 2007; 37: 846-855
        • Srivastava K.D.
        • Qu C.
        • Zhang T.
        • et al.
        Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.
        J Allergy Clin Immunol. 2009; 123: 443-451
        • Oppenheimer J.J.
        • Nelson H.S.
        • Bock S.A.
        • et al.
        Treatment of peanut allergy with rush immunotherapy.
        J Allergy Clin Immunol. 1992; 90: 256-262
        • Nelson H.S.
        • Lahr J.
        • Rule R.
        • et al.
        Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract.
        J Allergy Clin Immunol. 1997; 99: 744-751
        • Asero R.
        Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients.
        Clin Exp Allergy. 1998; 28: 1368-1373
        • Asero R.
        How long does the effect of birch pollen injection SIT on apple allergy last?.
        Allergy. 2003; 58: 435-438
        • Bucher X.
        • Pichler W.J.
        • Dahinden C.A.
        • et al.
        Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.
        Allergy. 2004; 59: 1272-1276
        • Bolhaar S.T.
        • Tiemessen M.M.
        • Zuidmeer L.
        • et al.
        Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges.
        Clin Exp Allergy. 2004; 34: 761-769
        • Alonso R.
        • Enrique E.
        • Pineda F.
        • et al.
        An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
        Int Arch Allergy Immunol. 2007; 143: 185-189
        • Kinaciyan T.
        • Jahn-Schmid B.
        • Radakovics A.
        • et al.
        Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1.
        J Allergy Clin Immunol. 2007; 119: 937-943
        • Schofield A.T.
        A case of egg poisoning.
        Lancet. 1908; 1: 716
        • Chehade M.
        • Mayer L.
        Oral tolerance and its relation to food hypersensitivities.
        J Allergy Clin Immunol. 2005; 115: 3-12
        • Strid J.
        • Hourihane J.
        • Kimber I.
        • et al.
        Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.
        Clin Exp Allergy. 2005; 35: 757-766
        • Patriarca C.
        • Romano A.
        • Venuti A.
        • et al.
        Oral specific hyposensitization in the management of patients allergic to food.
        Allergol Immunopathol (Madr). 1984; 12: 275-281
        • Patriarca G.
        • Schiavino D.
        • Nucera E.
        • et al.
        Food allergy in children: results of a standardized protocol for oral desensitization.
        Hepatogastroenterology. 1998; 45: 52-58
        • Patriarca G.
        • Nucera E.
        • Roncallo C.
        • et al.
        Oral desensitizing treatment in food allergy: clinical and immunological results.
        Aliment Pharmacol Ther. 2003; 17: 459-465
        • Patriarca G.
        • Nucera E.
        • Pollastrini E.
        • et al.
        Oral rush desensitization in peanut allergy: a case report.
        Dig Dis Sci. 2006; 51: 471-473
        • Rolinck-Werninghaus C.
        • Staden U.
        • Mehl A.
        • et al.
        Specific oral tolerance induction with food in children: transient or persistent effect on food allergy?.
        Allergy. 2005; 60: 1320-1322
        • Staden U.
        • Rolinck-Werninghaus C.
        • Brewe F.
        • et al.
        Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction.
        Allergy. 2007; 62: 1261-1269
        • Skripak J.M.
        • Nash S.D.
        • Rowley H.
        • et al.
        A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow’s milk allergy.
        J Allergy Clin Immunol. 2008; 122: 1154-1160
        • Longo G.
        • Barbi E.
        • Berti I.
        • et al.
        Specific oral tolerance induction in children with very severe cow’s milk-induced reactions.
        J Allergy Clin Immunol. 2008; 121: 343-347
        • Buchanan A.D.
        • Green T.D.
        • Jones S.M.
        • et al.
        Egg oral immunotherapy in nonanaphylactic children with egg allergy.
        J Allergy Clin Immunol. 2007; 119: 199-205
        • Jones S.M.
        • Pons L.
        • Roberts J.L.
        • et al.
        Clinical efficacy and immune regulation with peanut oral immunotherapy.
        J Allergy Clin Immunol. 2009; 124: 292-300
        • Clark A.T.
        • Islam S.
        • King Y.
        • et al.
        Successful oral tolerance induction in severe peanut allergy.
        Allergy. 2009; 64: 1218-1220
        • Hofmann A.M.
        • Scurlock A.M.
        • Jones S.M.
        • et al.
        Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
        J Allergy Clin Immunol. 2009; 124: 286-291
        • Narisety S.D.
        • Skripak J.M.
        • Steele P.
        • et al.
        Open-label maintenance after milk oral immunotherapy for IgE-mediated cow’s milk allergy.
        J Allergy Clin Immunol. 2009; 124: 610-612
        • Varshney P.
        • Steele P.H.
        • Vickery B.P.
        • et al.
        Adverse reactions during peanut oral immunotherapy home dosing.
        J Allergy Clin Immunol. 2009; 124: 1351-1352
        • Mempel M.
        • Rakoski J.
        • Ring J.
        • et al.
        Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy.
        J Allergy Clin Immunol. 2003; 111: 1406-1409
        • Kerzl R.
        • Simonowa A.
        • Ring J.
        • et al.
        Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation.
        J Allergy Clin Immunol. 2007; 119: 507-508
        • Enrique E.
        • Pineda F.
        • Malek T.
        • et al.
        Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
        J Allergy Clin Immunol. 2005; 116: 1073-1079
        • De Boissieu D.
        • Dupont C.
        Sublingual immunotherapy for cow’s milk protein allergy: a preliminary report.
        Allergy. 2006; 61: 1238-1239
        • Senti G.
        • Graf N.
        • Haug S.
        • et al.
        Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.
        J Allergy Clin Immunol. 2009; 124: 997-1002
        • Mondoulet L.
        • Dioszeghy V.
        • Ligouis M.
        • et al.
        Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.
        Clin Exp Allergy. 2010; 40: 659-667
        • Dupont C.
        • Kalach N.
        • Soulaines P.
        • et al.
        Cow’s milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity.
        J Allergy Clin Immunol. 2010; 125: 1165-1167
        • Nowak-Wegrzyn A.
        • Bloom K.A.
        • Sicherer S.H.
        • et al.
        Tolerance to extensively heated milk in children with cow’s milk allergy.
        J Allergy Clin Immunol. 2008; 122 (347): 342-347
        • Lemon-Mule H.
        • Sampson H.A.
        • Sicherer S.H.
        • et al.
        Immunologic changes in children with egg allergy ingesting extensively heated egg.
        J Allergy Clin Immunol. 2008; 122: 977-983
        • Wanich N.
        • Nowak-Wegrzyn A.
        • Sampson H.A.
        • et al.
        Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy.
        J Allergy Clin Immunol. 2009; 123: 789-794
        • Shreffler W.G.
        • Wanich N.
        • Moloney M.
        • et al.
        Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein.
        J Allergy Clin Immunol. 2009; 123: 43-52
        • Bannon G.A.
        • Cockrell G.
        • Connaughton C.
        • et al.
        Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy.
        Int Arch Allergy Immunol. 2001; 124: 70-72
        • Srivastava K.D.
        • Li X.M.
        • King N.
        • et al.
        Immunotherapy with modified peanut allergens in a murine model of peanut allergy.
        J Allergy Clin Immunol. 2002; 109 ([abstract]): S287
        • Li X.M.
        • Srivastava K.
        • Huleatt J.W.
        • et al.
        Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model.
        J Immunol. 2003; 170: 3289-3295
        • Li X.M.
        • Srivastava K.
        • Grishin A.
        • et al.
        Persistent protective effect of heat-killed Escherichia coli producing “engineered,” recombinant peanut proteins in a murine model of peanut allergy.
        J Allergy Clin Immunol. 2003; 112: 159-167
        • Kalliomaki M.
        • Salminen S.
        • Arvilommi H.
        Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.
        Lancet. 2001; 357: 1076-1079
        • Gruber C.
        • van S.M.
        • Mosca F.
        • et al.
        Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants.
        J Allergy Clin Immunol. 2010; 126: 791-797
        • Kalliomaki M.
        • Salminen S.
        • Poussa T.
        • et al.
        Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial.
        J Allergy Clin Immunol. 2007; 119: 1019-1021
        • Majamaa H.
        • Isolauri E.
        Probiotics: a novel approach in the management of food allergy.
        J Allergy Clin Immunol. 1997; 99: 179-185
        • Isolauri E.
        • Juntunen M.
        • Sillanaukee P.
        • et al.
        A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhea in children.
        Pediatrics. 1989; 88: 90-97
        • Pessi T.
        • Sutas Y.
        • Hurme M.
        • et al.
        Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG.
        Clin Exp Allergy. 2000; 30: 1804-1808
        • Sutas Y.
        • Hurme M.
        • Isolauri E.
        Downregulation of antiCD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes.
        Scand J Immunol. 1996; 43: 687-689
        • Frossard C.P.
        • Steidler L.
        • Eigenmann P.A.
        Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization.
        J Allergy Clin Immunol. 2007; 119: 952-959
        • Li S.
        • Li X.M.
        • Burks A.W.
        • et al.
        Modulation of peanut allergy by peptide-based immunotherapy.
        J Allergy Clin Immunol. 2001; 107 ([abstract]): S233
        • Horner A.A.
        • Nguyen M.D.
        • Ronaghy A.
        • et al.
        DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice.
        J Allergy Clin Immunol. 2000; 106: 349-356
        • Roy K.
        • Mao H.Q.
        • Huang S.K.
        • et al.
        Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.
        Nat Med. 1999; 5: 387-391
        • Nguyen M.D.
        • Cinman N.
        • Yen J.
        • et al.
        DNA-based vaccination for the treatment of food allergy.
        Allergy. 2001; 56: 127-130
        • Srivastava K.
        • Li X.M.
        • Bannon G.A.
        • et al.
        Investigation of the use of ISS-linked Ara h2 for the treatment of peanut-induced allergy.
        J Allergy Clin Immunol. 2001; 107 ([abstract]): S233